Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
American chemical industry news
(page 2)
26 April 2026
Toray launches 0.005 µm ultrafiltration module to reduce biofouling
Module enters mass production for wastewater reuse; cuts biopolymer permeate to ~1/3 vs conventional, reducing RO cleaning frequency, operational issues and reuse OPEX.
24 April 2026
Johnson & Johnson to acquire Atraverse Medical
Agreement to acquire a private med-device firm specializing in RF transseptal left-heart access; HOTWIRE RF guidewire (FDA-cleared) used in ≈3,000 procedures; expected close Q2 2026; terms undisclosed
24 April 2026
Iberdrola sells Mexico business
Mexico business sale completed: 2,600 MW (1,368 MW gas/cogeneration; 1,232 MW wind/solar), plus commercial ops and development projects; aligns with strategy to focus on contracted generation.
24 April 2026
BASF launches ELASTOSPRAY BMB biomass‑balance isocyanate for North American SPF market
Drop-in biomass-balance isocyanate for SPF systems requires no reformulation, offers 21-29% lower product carbon footprints, REDcert2-verified, supports EPDs and local renewable-energy production
24 April 2026
Chugai Q1 FY2026 Results
Core rev ¥321.7B (+11.5%), core OP ¥163.3B (+17.1%), core net ¥118.6B (+19.6%). Launched Elevidys (DMD JP); Lunsumio+Polivy approved for LBCL. R&D: NXT007 switch, Enspryng (MOGAD), Foundayo US approval.
24 April 2026
Kemira Q1 2026: Revenue and Profitability Down; Performance Actions Accelerated
Q1 revenue and margins fell due to weak demand, pricing and FX; volumes stable. Operative EBITDA down; operating cash flow improved. Outlook unchanged; cost and pricing measures accelerated.
How does the American chemical industry perform?
Find out with
chemXplore Alpha
Learn more
23 April 2026
Evonik launches Ancamine® 2873: ultra‑low‑emission, fast winter cure for protective and marine coatings
ULE epoxy curing agent enables fast cure at 5°C, low viscosity for sprayable high‑solids coatings, reduces VOCs, early water resistance, long pot life and corrosion protection.
23 April 2026
Honeywell Q1 Results, Reaffirms 2026 Outlook and Agrees to Sell Warehouse & Workflow Solutions
Q1: sales +2% organic, orders +7%, backlog $38.3B. Operating income -14% (impairments); segment profit +6% to $2.13B. Adjusted EPS +11% to $2.45; GAAP EPS $1.29.
23 April 2026
Dow Q1 2026 results
Q1: Net sales $9.8B (-6%); volumes -2%; local price -7%. GAAP loss $445M; operating EBIT $154M. Cash from ops $1.1B aided by NOVA payment. Sadara equity loss recognition suspended.
23 April 2026
Perpetual Next appoints Hans van Tuyll van Serooskerken to Supervisory Board
New appointee is CFO of NAM and ex‑Shell finance exec (former Finance Director at Pernis) with ~10 years in the Middle East, adding international finance expertise; a third board member is expected.
23 April 2026
Novo Nordisk: Oral semaglutide lowers HbA1c in adolescents with type 2 diabetes
PIONEER TEENS phase 3a: first oral GLP‑1 RA trial in 10–17‑year-olds with type 2 diabetes (n=132). 52‑week, placebo‑controlled; safety matched adult trials; regulatory filings planned H2.
23 April 2026
LKAB Q1 2026: Lower earnings, weaker market
Q1 net sales MSEK 7,907 (9,622); operating profit MSEK 860 (3,638). Weaker USD, lower pellet premiums and higher energy, plus transport and mine issues reduced volumes; ~2 Mt 2026 shortfall
23 April 2026
QatarEnergy ships first LNG export from Golden Pass LNG, Texas
First US LNG export cargo loaded on a 174,000 m³ carrier; marks move toward full commercial exports. Project >$10bn, 18 Mtpa capacity; first train produced 30 Mar 2026.
22 April 2026
INEOS: Project ONE could be Europe’s last petrochemical investment
€4.5bn for a new Antwerp ethylene cracker cutting CO2 by two‑thirds vs EU average; no Innovation Fund support. If ETS Booster won’t back it, Europe risks losing large-scale petrochemical investment.
22 April 2026
Air Liquide invests $350M+ in Louisiana to supply gases for Hyundai‑POSCO low‑carbon steel plant
Adding an ASU at a methanol site and extending pipeline along the Mississippi to boost methanol output, enable scalable, reliable gas supply for industrial decarbonization, with service from 2028.
22 April 2026
Johnson & Johnson — IMAAVY sustains disease control >2 years in antibody‑positive gMG
Phase 3 Vivacity-MG3 and OLE: nipocalimab shows >2-year sustained symptom control in antibody-positive gMG, durable MG-ADL/QMG gains, 50% MSE, steroid-sparing, IgG reduction >64%
22 April 2026
Chugai's FJ3 Fujieda API building wins ISPE 2026 Facility of the Year Honorable Mention
Facility enables dual production of macrocyclic‑peptide and small‑molecule APIs with advanced automation, parallel lines, 0.03 µg/m3 containment and global-scale supply.
22 April 2026
Croda Q1 2026 sales meet guidance
Q1 sales £431m, +1% CC; Beauty Actives and F&F offset weaker Crop Protection. Transformation on track; FY26 outlook unchanged. Latin America strongest; North America weaker.
22 April 2026
Mitsui Chemicals Expands Investment in U.S. PRT Developer Glydways
Investment advances deployment of on-demand PRT: small autonomous EVs platooning on dedicated lanes; demos in US and UAE; investor to supply materials, parts, regulatory and market support in Asia.
21 April 2026
Roche’s fenebrutinib halves RMS relapse rate to ~1 per 17 years
FENhance 1/2: the BTK inhibitor cut MRI lesion activity vs teriflunomide and showed trends to less disability; PPMS trial non‑inferior to ocrelizumab. Safety: similar LFTs; more deaths.
21 April 2026
FDA approves Merck’s IDVYNSO (doravirine/islatravir)
Once-daily, tenofovir-free two-drug regimen approved for virologically suppressed adults; Phase 3 non-inferior to BIC/FTC/TAF. Contraindicated with strong CYP3A inducers or 3TC/FTC; skin reactions.
21 April 2026
Roche's ENSPRYNG cuts MOGAD relapse risk by 68%
Phase III METEOROID met primary endpoint in MOGAD: treatment cut relapses vs placebo, reduced MRI lesions and rescue therapy use, showed consistent safety; data to be filed with regulators
21 April 2026
Genentech Enspryng cuts MOGAD relapse risk 68% in Phase III
METEOROID met its primary endpoint: drug delayed first relapse vs placebo, with early response (~8w), lower relapse rate, fewer MRI lesions and rescue tx; safety consistent; filings planned
21 April 2026
Merck and Eisai: LITESPARK‑012 triplet regimens fail to improve PFS and OS versus KEYTRUDA+LENVIMA in first‑line RCC
Phase 3 LITESPARK‑012 tested pembrolizumab+lenvatinib+belzutifan and a pembrolizumab+quavonlimab+lenvatinib regimen; safety profiles consistent with prior studies; full analysis ongoing.
21 April 2026
OCI Global sells remaining Methanex stake
Sold 2,612,962 shares (~3.4%) in a block trade at US$52.85 each on 20 April; net proceeds ≈US$138.1M. May acquire or dispose of such securities in the future.
21 April 2026
FDA accepts Roche sBLA for Gazyva/Gazyvaro in systemic lupus erythematosus (SLE)
ALLEGORY phase III: SRI‑4 response 76.7% vs 53.5% (adj diff 23.1%), doubled remission rates, fewer flares and reduced steroid use. FDA decision expected by Dec 2026.
20 April 2026
FDA Accepts Genentech sBLA for Gazyva in SLE
FDA accepted sBLA for an anti‑CD20 in SLE after Phase III ALLEGORY: SRI‑4 responders 76.7% vs 53.5%, higher remission, fewer flares and steroid reduction; decision due Dec 2026.
20 April 2026
Topsoe to supply HydroFlex for Abundia's plastic-to-fuel facilities
Selected tech will convert plastic waste into drop-in diesel, sustainable aviation fuel and chemical feedstock at three North American plants (1,500 bpd each). Baytown FID end-2026; ops 2029.
20 April 2026
Boehringer Ingelheim launches £150M AI accelerator in London’s Knowledge Quarter
Adds a new Computational Innovation centre to the global footprint, focusing on AI/ML for drug R&D to deepen disease biology and speed discovery; first 50 AI experts by end of 2027.
20 April 2026
PPG launches end-to-end data center protective coatings and application services
At Data Center World: demos of IEEE/UL‑compliant coating systems plus application and paint‑line design services; features EMI shielding, fire and corrosion protection, thermal reflectivity.
← Previous
Next →
